| 前收市價 | 199.10 |
| 開市 | 無 |
| 買盤 | 227.70 |
| 賣出價 | 231.45 |
| 拍板 | 450.00 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 199.10 - 199.10 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 無 |
Barrons.comThese Stocks Are Moving the Most Today: Apple, Amgen, Expedia, Coinbase, Cloudflare, Fortinet, Live Nation, and More
Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.
BenzingaMartin Shkreli Gets Scammed in Crypto Venture by Old Prison Friend, 'Don't Start Crypto Ventures With People You Meet in Prison
Controversial businessman Martin Shkreli, the former CEO of Turing Pharmaceuticals who raised the price of an essential drug from $13.50 to $750 per pill overnight, appears to have gained a new enemy. In a lengthy post on X, Shkreli shares that he "met this kid in prison" who "wanted to remake his life in crypto trading." In what Mr. Shkreli described as a "gesture of friendship", he gifted the friend 5 million tokens of a soon-to-be-released new project Martin Shkreli is working on. Don't Miss:
FortuneCoinbase knocked Q1 earnings out of the park—now comes the hard part
The crypto giant is riding high again, but the challenge, as always, is whether it can develop diverse revenue streams for the long haul.
